I’ve spent 11 years in pharma commercial operations and managed markets. I’ve spent the last few years specifically obsessing over the logistics of where our team actually gets things done. If I look at my spreadsheet—the one where I track “Who You Actually Meet” versus “Who You Were Promised You’d Meet”—the data is damning. Big conferences look great on a PowerPoint slide for leadership, but they rarely move the needle on a tough formulary hurdle.
When you’re dealing with the complexity of market access today, “great networking” is a meaningless phrase. It’s a placeholder for lazy planning. If you aren’t coming away with a specific lead on a policy barrier or a direct conversation about your pricing model, you’ve wasted your time. Let’s talk about why the shift toward the closed-door executive forum is the only way to drive formulary access execution.
The Illusion of the Big Congress Floor
We’ve all been to the massive congresses. Think of the scale of AMCP (Academy of Managed Care Pharmacy) or the specialized reach of the Association of Cancer Care Centers (ACCC). Are they important for visibility? Yes. Are they where you go to solve a multi-million dollar reimbursement block? Usually, no.
The problem with massive, open-access conferences is the signal-to-noise ratio. You’re competing with fifty other vendors, all fighting for the same thirty seconds of a payer’s attention while they’re rushing between sessions. It’s the professional equivalent https://highstylife.com/which-events-actually-move-the-needle-on-formulary-strategy/ of browsing a website that hits you with a Cookie Law Info plugin popup before you’ve even read the headline. Exactly.. It’s cluttered, it’s distracting, and it’s rarely where the real strategy happens.
When I look at our team’s participation in these events, I always ask: "What would I do differently on Monday?" If the answer is "nothing but catch up on emails," we shouldn't have gone.
The Power of the Closed-Door Executive Forum
This is where entities like The Health Management Academy (THMA) change the game. An executive forum isn't about collecting badges or handing out branded pens. It’s about health system decision-making in a room where the door is physically locked.
In these settings, you aren't talking to someone who *thinks* they know how the P&T committee works; you’re talking to the people who influence it. You’re discussing the reality of HTA (Health Technology Assessment) pressure, the specific constraints on your pricing, and why your value proposition is failing at the pharmacy director level.
Market Access vs. Prescriber Reach
Stop conflating the two. Big conferences are built for prescriber reach—showing off clinical data and getting a product name in front of a thousand sets of eyes. That’s brand marketing. Formulary access execution is an operational, financial, and logistical battle. It requires understanding Click for more the economic burden on a health system, not just the clinical utility of the drug.
I've seen this play out countless times: was shocked by the final bill.. At a closed-door forum, you can have a conversation about: The specific evidence gaps causing the formulary block. How digital tools in evidence generation and reimbursement can bridge the gap for a system that is struggling with manual data review. Why your rebate structure is missing the mark on total cost of care. The Comparison: Big Conference vs. Executive Forum I track these metrics because I’m tired of justifying budgets with empty metrics like "booth traffic." Below is how the reality breaks down when you analyze the ROI of your access strategy. Metric Big Congress (AMCP/ACCC) Closed-Door Executive Forum Primary Objective Brand Awareness / Market Presence Problem Solving / Strategic Partnership Decision-Maker Access Low (Passing interactions) High (Dedicated deep dives) Output Lead lists Actionable policy/formulary changes Risk of "Noise" High (Competitor clutter) Low (Curated environment) Pricing, Affordability, and the HTA Pressure The biggest frustration I hear from market access teams is that their pricing model "doesn't resonate" with payers. That’s because you’re pitching to a spreadsheet in your home office. In an executive forum, you hear the raw, uncomfortable truth about why your price point is a barrier to adoption. When you are face-to-face with an executive from a major health system, they aren't interested in "synergy" or "streamlining" your value story. They want to know the bottom line: does your drug reduce the operational friction in their system, or does it add to the burden? If you can’t answer that, no amount of glossy congress brochures will save your product from a restricted tier placement. Using Digital Tools to Bridge the Gap We’ve reached a point where analog relationships aren't enough. The best executive forums now leverage sophisticated digital tools in evidence generation and reimbursement to simulate the impact of a product *before* it hits the P&T committee. If you aren't bringing these tools into your forums, you’re missing the chance to let the payer "play" with your economic data. Use the forum to test the model. Let them see how changing the patient population or the discount assumptions changes the affordability. That isn't just networking; that is technical collaboration. The "Monday Morning" Test Every time I wrap up an event, I look at my notes. If I can’t write down three specific, tangible things to change by Monday morning, the event was a failure. The Insight: Did you learn why the P&T committee rejected your previous submission? (If they told you it was "price," dig deeper. It’s almost never just price.) The Partner: Did you meet one person who is willing to peer-review your value dossier or evidence deck? The Tech: Did you identify a gap where your current digital reimbursement tools are confusing the user rather than clarifying the value? If your strategy relies on "being visible" at every major congress in the country, you are burning cash on vanity metrics. Shift your focus to the small, high-stakes environments. Stop being a vendor who just shows up to hand out swag and start being a partner who comes to the table with a solution to the payer’s actual headache. The decision-makers are there. They’re just not standing on the trade show floor, waiting for you to hand them a brochure. They’re behind closed doors, trying to solve the exact problems you claim your product helps with. If you want real formulary access, you need to be in that room.
